| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
|---|---|---|
| Report Filing | 2025-05-15 | 2025-03-06 |
| Revenue | 0 | 0 |
| Cost of Revenue | 0 | 0 |
| Gross Profit | 0 | 0 |
| Operating Expenses | 2.02 | 13.53 |
| Research & Development | 0.617 | 5.39 |
| Selling, General and Administrative | 1.4 | 8.14 |
| Other Operating Expenses | 0 | 0 |
| Operating Income | -2.02 | -13.53 |
| Net Non-Operating Interest | -0.055 | -0.027 |
| Interest Income | 0 | 0.111 |
| Interest Expense | 0.055 | 0.138 |
| Equity & Other Income/(Expense) | 0.399 | -3.57 |
| Income Before Tax | -1.68 | -17.13 |
| Income Tax Expense | 0 | 0 |
| Income Attributable to Non-Controlling Interest | 0 | 0 |
| Net Income | -1.68 | -17.13 |
| Depreciation and Amortization | 0 | 0 |
| EBITDA | -2.02 | -13.53 |
| Earnings Per Share (EPS) | -0.13 | -1.42 |
| Diluted Earnings Per Share | -0.13 | -1.42 |
| Weighted Average Shares Outstanding | 12.9 | 12.1 |
| Diluted Weighted Average Shares Outstanding | 12.9 | 12.1 |
